Frances L Price, Phd, P.c. | |
1465 N 4th St Suite 101 Laramie WY 82072-2066 | |
(307) 745-3668 | |
Not Available |
Full Name | Frances L Price, Phd, P.c. |
---|---|
Speciality | Psychologist |
Location | 1465 N 4th St, Laramie, Wyoming |
Authorized Official Name and Position | Frances Price (OWNER) |
Authorized Official Contact | 3077604656 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Frances L Price, Phd, P.c. Po Box 2417 Cheyenne WY 82003-2417 Ph: () - | Frances L Price, Phd, P.c. 1465 N 4th St Suite 101 Laramie WY 82072-2066 Ph: (307) 745-3668 |
NPI Number | 1104137819 |
---|---|
Provider Enumeration Date | 06/28/2010 |
Last Update Date | 10/07/2022 |
Certification Date | 10/07/2022 |
Medicare PECOS PAC ID | 6800912171 |
---|---|
Medicare Enrollment ID | O20100923000721 |
News Archive
Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, has moved its global corporate headquarters from Waltham, MA to Burlington, MA. The significantly larger office space located at 8 New England Executive Park in Burlington, MA allows the Company to plan for future growth.
The start of the New Year often brings great intentions and an ambitious list of resolutions — some attainable and most? Completely unsustainable. For many, personal resolutions to achieving better health, such as weight loss or quitting smoking, wane quickly along with the initial good objectives and keen enthusiasm.
Research at The City College of New York shows that cancer imaging can be simplified by a photonic process utilizing molecules derived from horse chestnuts.
Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.
› Verified 6 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1104137819 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103T00000X | Psychologist | 354 (Wyoming) | Primary |
Provider Name | Frances L Price |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1912964487 PECOS PAC ID: 5890711303 Enrollment ID: I20051024000179 |
News Archive
Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, has moved its global corporate headquarters from Waltham, MA to Burlington, MA. The significantly larger office space located at 8 New England Executive Park in Burlington, MA allows the Company to plan for future growth.
The start of the New Year often brings great intentions and an ambitious list of resolutions — some attainable and most? Completely unsustainable. For many, personal resolutions to achieving better health, such as weight loss or quitting smoking, wane quickly along with the initial good objectives and keen enthusiasm.
Research at The City College of New York shows that cancer imaging can be simplified by a photonic process utilizing molecules derived from horse chestnuts.
Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.
› Verified 6 days ago
News Archive
Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, has moved its global corporate headquarters from Waltham, MA to Burlington, MA. The significantly larger office space located at 8 New England Executive Park in Burlington, MA allows the Company to plan for future growth.
The start of the New Year often brings great intentions and an ambitious list of resolutions — some attainable and most? Completely unsustainable. For many, personal resolutions to achieving better health, such as weight loss or quitting smoking, wane quickly along with the initial good objectives and keen enthusiasm.
Research at The City College of New York shows that cancer imaging can be simplified by a photonic process utilizing molecules derived from horse chestnuts.
Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.
› Verified 6 days ago
Cathedral Home For Children Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4989 N 3rd St, Laramie, WY 82072 Phone: 307-745-8997 | |
Pendley And Associates Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1277 N 15th St, Laramie, WY 82072 Phone: 307-742-6222 | |
Ark Regional Services, Inc. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1150 N 3rd St, Laramie, WY 82072 Phone: 307-742-6641 Fax: 307-742-9203 | |
Overcomer Counseling Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 265 N 4th St, Laramie, WY 82072 Phone: 307-399-0791 | |
Cathedral Home For Children Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4989 N 3rd St, Laramie, WY 82072 Phone: 307-745-8997 Fax: 307-742-6146 | |
Integrative Well-being Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1622 Shield St, Laramie, WY 82072 Phone: 307-760-5450 | |
Aktos Analytics, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1465 N 4th St, Suite #119, Laramie, WY 82072 Phone: 307-721-0700 |